Literature DB >> 24300552

Human immunodeficiency virus type 1 Vpr polymorphisms associated with progressor and nonprogressor individuals alter Vpr-associated functions.

Kevin Hadi1, Leah A Walker1, Debjani Guha1, Ramachandran Murali2, Simon C Watkins3, Patrick Tarwater4, Alagarsamy Srinivasan5, Velpandi Ayyavoo1.   

Abstract

Following infection with Human immunodeficiency virus 1 (HIV-1) there is a remarkable variation in virus replication and disease progression. Both host and viral factors have been implicated in the observed differences in disease status. Here, we focus on understanding the contribution of HIV-1 viral protein R (Vpr) by evaluating the disease-associated Vpr polymorphism and its biological functions from HIV-1 positive rapid progressor (RP) and long-term nonprogressor (LTNP) subjects. Results presented here show distinct variation in phenotypes of Vpr alleles from LTNP and RP subjects. Most notably, the polymorphism of Vpr at R36W and L68M associated with RP shows higher levels of oligomerization, and increased virus replication, whereas R77Q exhibits poor replication kinetics. Interestingly, we did not observe correlation with cell cycle arrest function. Together these results indicate that polymorphisms in Vpr in part may contribute to altered virus replication kinetics leading to the observed differences in disease progression in LTNP and RP groups.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24300552      PMCID: PMC3929175          DOI: 10.1099/vir.0.059576-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  40 in total

1.  Modulation of NKG2D-mediated cytotoxic functions of natural killer cells by viral protein R from HIV-1 primary isolates.

Authors:  Tram N Q Pham; Jonathan Richard; Francine C A Gerard; Christopher Power; Éric A Cohen
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

Review 2.  HIV pathogenesis: knowledge gained after two decades of research.

Authors:  J A Levy
Journal:  Adv Dent Res       Date:  2006-04-01

3.  HIV VprR77Q mutation does not influence clinical response of individuals initiating highly active antiretroviral therapy.

Authors:  Celia Chui; Peter K Cheung; Chanson J Brumme; Theresa Mo; Zabrina L Brumme; Julio S G Montaner; Andrew D Badley; P Richard Harrigan
Journal:  AIDS Res Hum Retroviruses       Date:  2006-07       Impact factor: 2.205

4.  Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex.

Authors:  S Popov; M Rexach; L Ratner; G Blobel; M Bukrinsky
Journal:  J Biol Chem       Date:  1998-05-22       Impact factor: 5.157

5.  Viral genetic determinants of nonprogressive HIV type 1 subtype C infection in antiretroviral drug-naive children.

Authors:  D B Tzitzivacos; C T Tiemessen; W S Stevens; M A Papathanasopoulos
Journal:  AIDS Res Hum Retroviruses       Date:  2009-11       Impact factor: 2.205

6.  Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr.

Authors:  S Mahalingam; V Ayyavoo; M Patel; T Kieber-Emmons; D B Weiner
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

7.  Functional conservation of HIV-1 Vpr and variability in a mother-child pair of long-term non-progressors.

Authors:  Yuqi Zhao; Mingzhong Chen; Bin Wang; June Yang; Robert T Elder; Xiang-qian Song; Min Yu; Nitin K Saksena
Journal:  Virus Res       Date:  2002-10       Impact factor: 3.303

8.  Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection.

Authors:  Berta Rodés; Carlos Toro; Ellen Paxinos; Eva Poveda; Manuel Martinez-Padial; José Miguel Benito; Victoria Jimenez; Terri Wrin; Sylvina Bassani; Vincent Soriano
Journal:  AIDS       Date:  2004-05-21       Impact factor: 4.177

9.  Genomic analysis of HIV type 1 strains derived from a mother and child pair of long-term nonprogressors.

Authors:  Milan Reinis; Barbara Weiser; Carla Kuiken; Tao Dong; Dorothy Lang; Sharon Nachman; Yonghong Zhang; Sarah Rowland-Jones; Harold Burger
Journal:  AIDS Res Hum Retroviruses       Date:  2007-02       Impact factor: 2.205

10.  Nef gene evolution from a single transmitted strain in acute SIV infection.

Authors:  Benjamin N Bimber; Pauline Chugh; Elena E Giorgi; Baek Kim; Anthony L Almudevar; Stephen Dewhurst; David H O'Connor; Ha Youn Lee
Journal:  Retrovirology       Date:  2009-06-08       Impact factor: 4.602

View more
  8 in total

1.  Vpr Enhances Tumor Necrosis Factor Production by HIV-1-Infected T Cells.

Authors:  Ferdinand Roesch; Léa Richard; Réjane Rua; Françoise Porrot; Nicoletta Casartelli; Olivier Schwartz
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

2.  The degree of HIV-1 amino acid variability is strictly related to different disease progression rates.

Authors:  Rossana Scutari; Monica Faieta; Roberta D'Arrigo; Lavinia Fabeni; Cristina Mussini; Andrea Cossarizza; Claudio Casoli; Carlo Federico Perno; Valentina Svicher; Claudia Alteri; Stefano Aquaro
Journal:  Virus Genes       Date:  2018-05-17       Impact factor: 2.332

3.  Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status.

Authors:  Will Dampier; Gregory C Antell; Benjamas Aiamkitsumrit; Michael R Nonnemacher; Jeffrey M Jacobson; Vanessa Pirrone; Wen Zhong; Katherine Kercher; Shendra Passic; Jean W Williams; Tony James; Kathryn N Devlin; Tania Giovannetti; David J Libon; Zsofia Szep; Garth D Ehrlich; Brian Wigdahl; Fred C Krebs
Journal:  J Neurovirol       Date:  2016-07-11       Impact factor: 2.643

4.  HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages.

Authors:  Hichem Lahouassa; Marie-Lise Blondot; Lise Chauveau; Ghina Chougui; Marina Morel; Marjorie Leduc; François Guillonneau; Bertha Cecilia Ramirez; Olivier Schwartz; Florence Margottin-Goguet
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

Review 5.  The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention.

Authors:  María Eugenia González
Journal:  Int J Mol Sci       Date:  2017-01-10       Impact factor: 5.923

6.  Immune escape mutations in HIV-1 controllers in the Brazilian Amazon region.

Authors:  Samara Tatielle Monteiro Gomes; Ednelza da Silva Graça Amoras; Érica Ribeiro Gomes; Maria Alice Freitas Queiroz; Edivaldo Costa Sousa Júnior; Janaína Mota de Vasconcelos Massafra; Poliana da Silva Lemos; João Lídio Vianez Júnior; Ricardo Ishak; Antonio Carlos Rosário Vallinoto
Journal:  BMC Infect Dis       Date:  2020-07-25       Impact factor: 3.090

Review 7.  Vpr and Its Cellular Interaction Partners: R We There Yet?

Authors:  Helena Fabryova; Klaus Strebel
Journal:  Cells       Date:  2019-10-24       Impact factor: 6.600

Review 8.  Host Restriction Factors Modulating HIV Latency and Replication in Macrophages.

Authors:  Isabel Pagani; Pietro Demela; Silvia Ghezzi; Elisa Vicenzi; Massimo Pizzato; Guido Poli
Journal:  Int J Mol Sci       Date:  2022-03-11       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.